उत्पाद विवरण
1. Technical Specifications
| Attribute |
Details |
| Brand Name |
Lmwx 40 Injection |
| Active Ingredient |
Enoxaparin Sodium (Low Molecular Weight Heparin) |
| Strength |
40 mg/0.4 ml prefilled syringe |
| Dosage Form |
Injection (subcutaneous/IV) |
| Packaging Size |
1 prefilled syringe |
| Packaging Type |
Prefilled glass syringe with needle |
| Medicine Type |
Allopathic, Anticoagulant (LMWH) |
| Manufactured By |
Abbott India Ltd. |
| Distributed By |
Authorized pharmaceutical distributors |
2. Product Description
Lmwx 40 Injection contains Enoxaparin Sodium, a low molecular weight heparin (LMWH) used as an anticoagulant. It prevents the formation of harmful blood clots by enhancing the activity of antithrombin III, which inhibits clotting factors (Factor Xa and thrombin). It is widely used for prophylaxis and treatment of deep vein thrombosis (DVT), pulmonary embolism (PE), and to prevent clotting during surgeries or in patients with restricted mobility.
3. Product Highlights
| Attribute |
Details |
| Generic Name |
Enoxaparin Sodium |
| Therapeutic Category |
Anticoagulant (LMWH) |
| Application Area |
Cardiovascular, Hematology, Surgery |
| Administration |
Subcutaneous (main route), IV in special cases |
| Onset of Action |
Within 35 hours after injection |
| Storage Conditions |
Store below 25C, protect from light and freezing |
4. Therapeutic Uses
-
Prevention of Deep Vein Thrombosis (DVT) in patients undergoing orthopedic or abdominal surgery
-
Treatment of DVT and Pulmonary Embolism (PE)
-
Prevention of clotting in bedridden/immobilized patients
-
Prevention of ischemic complications in patients with unstable angina and myocardial infarction
-
Used during dialysis to prevent clot formation in extracorporeal circuits
5. Side Effects
Common:
-
Pain, redness, or bruising at injection site
-
Mild bleeding or bruising easily
-
Nausea, diarrhea
Serious (rare):
-
Major bleeding (internal bleeding, blood in urine/stool, coughing blood)
-
Heparin-induced thrombocytopenia (HIT) low platelet count
-
Allergic reactions (rash, swelling, breathing difficulty)
-
Elevated liver enzymes
6. Precautions
-
Use only under doctors prescription and supervision
-
Contraindicated in active major bleeding or history of heparin-induced thrombocytopenia (HIT)
-
Dose adjustment required in renal impairment
-
Monitor platelet counts and coagulation profile during therapy
-
Avoid use with other anticoagulants/antiplatelets unless advised (increases bleeding risk)
-
Inform doctor before any surgery or dental procedure
-
Use with caution in pregnant women; generally avoided in breastfeeding unless clearly prescribed
Reliable Anticoagulant SolutionLMWX-40 Enoxaparin Injection, containing 40 mg/0.04 ml of enoxaparin sodium, is a trusted choice for preventing and treating deep vein thrombosis and associated complications. Its efficacy and safety profile make it a preferred option for doctors treating adult patients at risk of blood clots.
Strict Dosage and Usage GuidelinesThis medication must be used strictly as per a doctors instructions. Dosage is tailored to the patients condition, and administration is performed through subcutaneous injection by qualified medical staff. Following the prescribed regimen is crucial for optimal therapeutic results.
Ideal Distribution for Healthcare ProvidersOffered by distributors, exporters, suppliers, traders, and wholesalers in India, LMWX-40 Enoxaparin is particularly suitable for hospitals, clinics, and healthcare institutions responsible for adult patient care. Proper storage ensures maintenance of product integrity until it is dispensed.
FAQs of LMWX-40 Enoxaparin Injection 40 mg/0.04 ml:
Q: How should LMWX-40 Enoxaparin Injection be administered?
A: LMWX-40 Enoxaparin Injection is given via subcutaneous injection, typically by a healthcare professional. It should always be used according to the dosage and methods prescribed by a doctor.
Q: What is the recommended dosage for LMWX-40 Enoxaparin Injection?
A: Dosage guidelines vary depending on the patients medical condition and are determined by the prescribing doctor. Patients should not attempt to self-administer or alter the dose without medical advice.
Q: When is LMWX-40 Enoxaparin Injection prescribed?
A: This injection is recommended for adults to prevent and treat blood clots, such as deep vein thrombosis, especially following surgeries or in immobilized patients, as determined by a healthcare provider.
Q: Where should LMWX-40 Enoxaparin Injection be stored?
A: LMWX-40 should be kept in a cool and dry place, away from direct heat and light, to preserve its effectiveness until used.
Q: What is the primary benefit of using LMWX-40 Enoxaparin Injection?
A: The main advantage is its ability to effectively reduce the risk of dangerous blood clots in adults, supporting recovery and preventing complications after surgeries or during prolonged immobility.
Q: How can distributors or wholesalers purchase LMWX-40 Enoxaparin?
A: Distributors, exporters, suppliers, traders, and wholesalers in India can source this product directly from authorized pharmaceutical suppliers, ensuring compliance with all regulatory standards.